Episode 190: ASCO Updates in GU Oncology

I am joined on this special Healthcare Unfiltered podcast by Drs. Rana McKay and Petros Grivas to discuss the latest genitourinary oncology research updates from the 2024 ASCO Annual Meeting, covering topics such as the prognostic ability of KIM-1 in kidney cancer, patient-reported outcomes from enfortumab vedotin/pembrolizumab treatment, and the final overall survival update from the JAVELIN Renal 101 trial.

The conversation also delves into studies on IO/TKI biomarkers, adaptive trials with ctDNA, and the latest findings from trials like KEYNOTE-426, CLEAR, PSMAfore, and SURE-01. Don’t miss it – lots of fun, science, and humor.

Related Resources

N/A

Subscribe to Healthcare Unfiltered

Other Episodes You May Enjoy...